| From : | Liu, Alvin <Alvin.Liu@pfizer.com> |
| To : | Tamar Gabunia <tgabunia@moh.gov.ge>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com> |
| Subject : | RE: Pfizer/BioNTech- Quality Form and Shipping Information |
| Cc : | Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>; gkhalil@unicef.org; domentes@who.int; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>; etikaradze@yahoo.de; sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; etikaradze@yahoo.de |
| Received On : | 26.03.2021 22:22 |
| Attachments : |
Great thank you Dr. Gabunia. Also, I heard from our team the vaccines arrived in good order today and we received confirmation that the quality disposition was complete.
Thank you again to you and your team for your patience and interest in our vaccine – hopeful this first delivery will support the government of Georgia’s pandemic response. Have a good weekend ahead.
Regards,
Alvin
From: Tamar Gabunia
Sent: Tuesday, March 23, 2021 12:15 AM
To: Liu, Alvin
Cc: Maia Nikoleishvili
Subject: [EXTERNAL] RE: Pfizer/BioNTech- Quality Form and Shipping Information
Dear Alvin
Thanks for your reply, Hereby I confirm that the Tbilisi Central Warehouse, Kutaisi Regional Warehouse and Batumi Regional Warehouse all will have Ultra low temperature
(ULT) freezers to store the vaccine. Thank you for sharing the redistribution considerations, this is very helpful.
With kind regards
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister
From: Liu, Alvin [mailto:Alvin.Liu@pfizer.com]
Sent: 23 March, 2021 00:05
To: Tamar Gabunia <tgabunia@moh.gov.ge>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
etikaradze@yahoo.de;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>;
etikaradze@yahoo.de
Subject: RE: Pfizer/BioNTech- Quality Form and Shipping Information
Thank you Dr. Gabunia. Please let me confirm that the Tbislisi Central Warehouse, Kutaisi Regional Warehouse and Batumi Regional Warehouse all will have Ultra low temperature
(ULT) freezers to store the vaccine? We do not need an official translation of the additional guidance the government has provided, we just would like to reconfirm the cold chain strategy for managing the distribution of the vaccine once it arrives to Tbislisi.
Thanks in advance – I’ve attached a resource that our supply chain team has developed in case you it may be useful for your team. Appreciate the timely follow-up.
Regards,
Alvin
From: Tamar Gabunia <tgabunia@moh.gov.ge>
Sent: Monday, March 22, 2021 3:11 PM
To: Liu, Alvin <Alvin.Liu@pfizer.com>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
etikaradze@yahoo.de;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>;
etikaradze@yahoo.de
Subject: [EXTERNAL] RE: Pfizer/BioNTech- Quality Form and Shipping Information
Dear Alvin
Many thanks for your e-mail and this update. Great to hear that the vaccines and diluent will be delivered this Wednesday. Attached you can find the National
Vaccine Deployment Plan which provides consideration for storage and distribution of the ultra-cold chain vaccines. Beside this, the Governmental order specifies additional requirements for Pfizer vaccine administering clinical sites. We have it available
in Georgian language. Please kindly let me know if you would like to have a copy in English.
With kind regards
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister
From: Liu, Alvin [mailto:Alvin.Liu@pfizer.com]
Sent: 22 March, 2021 21:54
To: Tamar Gabunia <tgabunia@moh.gov.ge>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Hannah Kettler (Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
etikaradze@yahoo.de;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>;
etikaradze@yahoo.de
Subject: RE: Pfizer/BioNTech- Quality Form and Shipping Information
Dear Dr. Gabunia,
Thank you again for providing all of the documentation. We are currently planning for delivery of both the vaccine and diluent this week on Wednesday. I went through all
of the forms you sent and realized I did not have a copy of your national vaccine deployment plan outlining the government of Georgia’s considerations of storage and in-country distribution of Covid-19 vaccines requiring ultra cold-chain. When you get a moment
could you please forward it to me? Please do not hesitate to reach out with any further questions. Many thanks.
Regards,
Alvin
From: Tamar Gabunia <tgabunia@moh.gov.ge>
Sent: Friday, March 5, 2021 11:40 AM
To: Liu, Alvin <Alvin.Liu@pfizer.com>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler
(Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
etikaradze@yahoo.de;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>;
etikaradze@yahoo.de
Subject: [EXTERNAL] Pfizer/BioNTech- Quality Form and Shipping Information
Dear Alvin
Many thanks for addressing our questions related to the importer of record, shipping locations and quality forms. Please find attached completed and singed documents. In addition I am sending
NRA letter expressing regulatory readiness on issuing the import permit immediately upon receiving the shipping documents. Mr. Otar Namicheishvili, is in charge of clearance procedures on behalf of the National Center for Disease Control and Public Health
Contact Information:
Otar Namicheishvili
+995 577 388 000
Please kindly let me know if anything else is required.
With kind regards
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister
From: Liu, Alvin [mailto:Alvin.Liu@pfizer.com]
Sent: 5 March, 2021 07:27
To: Tamar Gabunia <tgabunia@moh.gov.ge>; Rosie Grieves (Consultant <rgrieves@gavi.org>; O'Neill, Jillian R <JillianR.ONeill@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler
(Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
etikaradze@yahoo.de;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>;
etikaradze@yahoo.de
Subject: RE: Pfizer/BioNTech- Indemnification Agreement
Dear Dr. Gabunia,
Thank you for sending the executed agreements. Our legal team is finalizing their review and hope to have fully executed documents to you shortly. In advance of our call
tomorrow, I am attaching two documents for your review that we will briefly cover confirming details of:
The forms do not need to be completed ahead of the call as we will briefly discuss the requirements with you however as both are required for us to start the process of confirming
delivery logistics, it would be great to have them returned by this coming Monday (or sooner if you already have the necessary information). I will be sharing some additional information with you during the call – no need to prepare anything in advance as
the rest of the items we hope will be relatively straight forward. We are looking forward to meeting with you and the team tomorrow!
With our thanks in advance.
Regards,
Alvin
From: Tamar Gabunia <tgabunia@moh.gov.ge>
Sent: Monday, March 1, 2021 8:08 AM
To: Rosie Grieves (Consultant <rgrieves@gavi.org>; Akande, Michelle <Michelle.Akande@pfizer.com>; Sousa, Patricia <Patricia.A.Sousa@pfizer.com>;
Liu, Alvin <Alvin.Liu@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler
(Consultant <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
etikaradze@yahoo.de;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>;
etikaradze@yahoo.de
Subject: [EXTERNAL] FW: Pfizer/BioNTech- Indemnification Agreement
Importance: High
Dear Pfizer Colleagues
Dear Rosie
As advised by the Letter issued on February 22nd, we are waiting for the time for the tripartite teleconsultation. However, meanwhile I am sending the signed In&L agreement and the
side letter for your review and approval. We will be making amendments as needed after the call.
I look forward to hearing from you on next steps.
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister
From: Tamar Gabunia [mailto:tgabunia@moh.gov.ge]
Sent: Friday, February 26, 2021 9:39 PM
To: Rosie Grieves (Consultant) <rgrieves@gavi.org>; Akande, Michelle <Michelle.Akande@pfizer.com>; Sousa, Patricia <Patricia.A.Sousa@pfizer.com>;
Liu, Alvin HL <alvin.liu@pfizer.com>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler
(Consultant) <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
etikaradze@yahoo.de;
sgagua@gov.ge
Subject: Pfizer/BioNTech- Indemnification Agreement
Importance: High
Dear Pfizer Colleagues
Dear Rosie
The Government of Georgia has been advised by the Director-General of WHO - Dr Tedros Adhanom Ghebreyesus that one of the prerequisites for urgently accelerating
deployment of Pfizer-BioNtech vaccine to Georgia was confirmation that the arbitration provision in the Indemnification Agreement and Side Letter is enforceable. With this e-mail I am sending the letter issued by the Ministry of Justice of Georgia confirming
that the arbitration provision in the above mentioned agreement is enforceable in Georgia. Please find the attached letter.
I look forward to our tripartite teleconsultation next week to finalize endorsement of the agreement and a side letter.
Many thanks for your cooperation.
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister
From: Rosie Grieves (Consultant) [mailto:rgrieves@gavi.org]
Sent: 22 February, 2021 21:32
To: Tamar Gabunia <tgabunia@moh.gov.ge>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
gkhalil@unicef.org;
domentes@who.int; Santiago Cornejo <scornejo@gavi.org>; Sam Muller <smuller@gavi.org>; Pascal Bijleveld <pbijleveld@gavi.org>; Hannah Kettler
(Consultant) <hkettler@gavi.org>; Katherine Hudak <khudak@gavi.org>; Dorcas Noertoft <dnoertoft@unicef.org>; Liu, Alvin HL <alvin.liu@pfizer.com>;
Akande, Michelle <Michelle.Akande@pfizer.com>; Sousa, Patricia <Patricia.A.Sousa@pfizer.com>
Subject: Update on Pfizer/BioNTech
Dear Tamar,
I am writing to share an update on the initial limited volume of the COVID-19 vaccine requiring ultra-cold chain produced by Pfizer/BioNTech. After several conversations with Pfizer over the last three weeks, we
can now provide more information for your planning purposes. Thank you for your patience as we have worked through these issues.
Key next steps are outlined in the letter attached. I will be in touch to arrange a meeting for later this week between Pfizer, Government of Georgia
and Covax to discuss further.
Best wishes
Rosie
Rosie Grieves
Senior Manager Country Engagement
Mobile: +44 7849 574189
Web: gavi.org
NOTICE: This email, including any attachments to it, may be confidential and does not create any binding contract on behalf
of Gavi or its partners.
If this email was sent to you in error, please notify the send